Special Issue "Leukemia"

Quicklinks

A special issue of Cancers (ISSN 2072-6694).

Deadline for manuscript submissions: closed (31 July 2012)

Special Issue Editor

Guest Editor
Dr. Charles H. Lawrie
Lymphoid Malignancy Research Group, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, UK
Website: http://www.intechopen.com/profiles/103158/charles-lawrie
E-Mail: charles.lawrie@ndcls.ox.ac.uk
Phone: +44 1865 220344
Interests: cancer; lymphoma; leukemia; microarray; microRNA; biomarkers; non-coding RNA

Special Issue Information

Dear Colleagues,

Leukemia (leukaemia- British spelling) is a malignancy of the blood originating from immature leukocytes (lymphoid and myeloid). It is the most common form of childhood cancer (~1/3 of cases) and accounts for >44,000 new diagnoses and >22,000 mortalities annually in the US alone. Recent advances in both laboratory and clinic continue to improve the outcome for patients. This special edition of Cancers gives an opportunity to describe recent original research in the field of leukemia, the development or application of new platforms or insights, and/or reviews of the field. We are particularly interested in genomics, leukemia stem cell research, novel therapeutics, epidemiological studies and new biomarker studies. If you would like to discuss an idea for a paper before committing please contact the guest editor.

Dr. Charles Lawrie
Guest Editor

Keywords

  • acute lymphoblastic leukemia (ALL)
  • chronic lymphocytic leukemia (CLL)
  • acute myelogenous leukemia (AML)
  • chronic myelogenous leukemia (CML)
  • hairy cell leukemia (HCL)
  • T-cell prolymphocytic leukemia (T-PLL)
  • large granular lymphocytic leukemia
  • adult T-cell leukemia
  • human T-lymphotropic virus (HTLV)

Published Papers (7 papers)

Cancers 2013, 5(1), 281-295; doi:10.3390/cancers5010281
Received: 31 January 2013; in revised form: 28 February 2013 / Accepted: 4 March 2013 / Published: 11 March 2013
Show/Hide Abstract | PDF Full-text (884 KB) | HTML Full-text | XML Full-text

Cancers 2012, 4(4), 1161-1179; doi:10.3390/cancers4041161
Received: 22 August 2012; in revised form: 29 September 2012 / Accepted: 17 October 2012 / Published: 2 November 2012
Show/Hide Abstract | PDF Full-text (422 KB) | HTML Full-text | XML Full-text

Cancers 2012, 4(4), 1050-1066; doi:10.3390/cancers4041050
Received: 26 July 2012; in revised form: 2 October 2012 / Accepted: 9 October 2012 / Published: 18 October 2012
Show/Hide Abstract | PDF Full-text (968 KB) | HTML Full-text | XML Full-text | Supplementary Files

Cancers 2012, 4(4), 1036-1049; doi:10.3390/cancers4041036
Received: 26 July 2012; in revised form: 14 September 2012 / Accepted: 9 October 2012 / Published: 18 October 2012
Show/Hide Abstract | Cited by 2 | PDF Full-text (733 KB) | HTML Full-text | XML Full-text

Cancers 2012, 4(3), 904-944; doi:10.3390/cancers4030904
Received: 2 August 2012; in revised form: 31 August 2012 / Accepted: 4 September 2012 / Published: 10 September 2012
Show/Hide Abstract | PDF Full-text (421 KB) | HTML Full-text | XML Full-text

Cancers 2012, 4(3), 743-762; doi:10.3390/cancers4030743
Received: 1 June 2012; in revised form: 11 July 2012 / Accepted: 13 July 2012 / Published: 25 July 2012
Show/Hide Abstract | PDF Full-text (359 KB) | HTML Full-text | XML Full-text

Cancers 2012, 4(2), 601-617; doi:10.3390/cancers4020601
Received: 17 May 2012; in revised form: 13 June 2012 / Accepted: 14 June 2012 / Published: 20 June 2012
Show/Hide Abstract | PDF Full-text (242 KB) | HTML Full-text | XML Full-text

Last update: 25 February 2014

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert